Vytrus Biotech’s 2024 Sustainability Report highlights major progress in plant stem cell innovation, resource savings, and ESG efforts. Key achievements include award-winning product Baolift™, strong certifications,...
Vytrus Biotech reported 76% sales growth in Q1 2025, with standout gains in Asia-Pacific (271%) and strong global performance. EBITDA doubled to €1.02 million. Its Exosomic...
Vytrus Biotech will present its Q3 2024 financials live on November 7, revealing record revenue of €4.6 million in the last year. Q3 sales rose by...